Divya Kumar Vemuri - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Biomedical Chromatography : BMC|March 16, 2022

Favipiravir (SARS-CoV-2) degradation impurities: Identification and route of degradation mechanism in the finished solid dosage form using LC/LC-MS methodDivya Kumar Vemuri, Rambabu Gundla, Naresh Konduru, et al.

Biomedical Chromatography : BMC|March 23, 2026

Quality by Design-Based Development of a Robust LC Method for Simultaneous Estimation of Process- and Degradation-Related Impurities in Rifapentine Drug Product for the Treatment of Active and Latent TuberculosisSiva Prasad Korikana, Sreenivasa Rao Battula, Naresh Konduru, et al.

ACS Omega|January 2, 2023

Unique Quality by Design Approach for Developing HPLC and LC-MS Method for Estimation of Process and Degradation Impurities in Pibrentasvir, Antiviral Agent for Hepatitis CDivya Kumar Vemuri, Parameswari Akshinthala, Naresh Konduru, et al.

ACS Omega|October 13, 2025

Quality-by-Design-Driven RP-HPLC Method Development and Validation for Impurity Analysis of Elexacaftor, a Cystic Fibrosis Drug, with LC-MS/MS-Based Degradant IdentificationJayaprakash Kanijam Raghupathi, Divya Kumar Vemuri, Syed Mastan Ali, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Biomedical Chromatography : BMC|March 16, 2022

Favipiravir (SARS-CoV-2) degradation impurities: Identification and route of degradation mechanism in the finished solid dosage form using LC/LC-MS methodDivya Kumar Vemuri, Rambabu Gundla, Naresh Konduru, et al.

Biomedical Chromatography : BMC|March 23, 2026

Quality by Design-Based Development of a Robust LC Method for Simultaneous Estimation of Process- and Degradation-Related Impurities in Rifapentine Drug Product for the Treatment of Active and Latent TuberculosisSiva Prasad Korikana, Sreenivasa Rao Battula, Naresh Konduru, et al.

ACS Omega|January 2, 2023

Unique Quality by Design Approach for Developing HPLC and LC-MS Method for Estimation of Process and Degradation Impurities in Pibrentasvir, Antiviral Agent for Hepatitis CDivya Kumar Vemuri, Parameswari Akshinthala, Naresh Konduru, et al.

ACS Omega|October 13, 2025

Quality-by-Design-Driven RP-HPLC Method Development and Validation for Impurity Analysis of Elexacaftor, a Cystic Fibrosis Drug, with LC-MS/MS-Based Degradant IdentificationJayaprakash Kanijam Raghupathi, Divya Kumar Vemuri, Syed Mastan Ali, et al.

Pageof 1